종양 전사체학 시장 : 제품 유형별, 용도별, 기술별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Tumor Transcriptomics Market size was valued at USD 5,790.10 Million in 2023, expanding at a CAGR of 10.10% from 2024 to 2032.

Tumor transcriptomics involves analyzing the gene expression profiles of tumors by examining RNA molecules (transcripts). This method identifies genes that are either over-expressed or under-expressed compared to healthy tissue, revealing the molecular characteristics of tumors. This approach offers insights into how tumors develop, progress, and potential targets for treatment. Tumor transcriptomics is crucial for personalized medicine as it allows for the identification of key mutations driving cancer and facilitates the customization of treatment plans based on the specific transcriptional profile of each tumor.

Tumor Transcriptomics Market- Market Dynamics

Increasing research and development in diagnostics and drug discovery to propel market demand

The growth of the transcriptomics market is being actively driven by increasing research and development in diagnostics and drug discovery, the rising prevalence of chronic diseases like cancer and neuromuscular disorders, and expanding applications of transcriptomics. Transcriptomics plays a crucial role in accelerating disease diagnostics, especially with the growing global burden of chronic diseases such as cancer and diabetes. For example, according to the GLOBOCAN 2020 report, there were approximately 19.2 million new cancer cases and 9.9 million cancer deaths worldwide. This increasing patient population is expected to positively impact market growth. The market growth is anticipated to be significantly driven by product launches, expansions, collaborations, and acquisitions from key market players. For example, in February 2020, Caris Life Sciences introduced its latest genomic profiling offering, MI Transcriptome, which utilizes Whole Transcriptome Sequencing (WTS). This technology enables detailed RNA profiling of patients' tumors, complementing Caris' comprehensive approach that assesses DNA, RNA, and proteins to tailor therapies accurately. Such launches are poised to positively impact market expansion. Similarly, in February 2020, Dovetail Genomics expanded its global reach with the availability of Dovetail HiChIP and Micro-C Kits, aiming to broaden its customer base worldwide and further stimulate market growth.

Tumor Transcriptomics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.10% over the forecast period (2024-2032)

Based on Product type segmentation, instruments was predicted to show maximum market share in the year 2023

Based on technology segmentation, sequencing technologies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Tumor Transcriptomics Market- Segmentation Analysis:

The Global Tumor Transcriptomics Market is segmented on the basis of Product type, Application, Technology, and Region.

The market is divided into three categories based on Product type: Consumables, Instruments, and Other Products. In terms of product types, instruments hold a dominant position due to their critical role in conducting transcriptomic analyses. Instruments such as microarray scanners, real-time quantitative PCR machines, and next-generation sequencing platforms are essential for generating data and performing high-throughput transcriptome analysis. These instruments are pivotal for researchers and clinicians seeking to understand disease mechanisms, identify biomarkers, and develop personalized treatment strategies, thereby solidifying their dominance in the market.

The market is divided into three categories based on technology: Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR) and Sequencing Technologies. In the transcriptomics market, sequencing technologies dominate the technology segment due to their advanced capabilities in analyzing the transcriptome with high resolution. RNA sequencing (RNA-Seq) has revolutionized transcriptomic studies by allowing researchers to detect rare transcripts, study alternative splicing events, and quantify gene expression levels accurately. This technology's ability to provide comprehensive insights into gene expression profiles and molecular pathways has made it indispensable in both research and clinical applications, driving its dominance in the market.

Tumor Transcriptomics Market- Geographical Insights

From a territorial perspective, this market covers a vast geographic area, stretching across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Individual countries within these regions create further market classifications. North America is projected to lead the market, fueled by favorable government initiatives, rising healthcare spending, a robust presence of industry leaders, advanced healthcare infrastructure, heightened awareness among healthcare stakeholders about available technologies, and a high concentration of market players, particularly in the United States.

Tumor Transcriptomics Market- Competitive Landscape:

The Tumor Transcriptomics market refers to the sector focused on the study and analysis of gene expression patterns in tumors. It involves technologies and methodologies aimed at understanding the transcriptome of cancer cells, which can provide insights into tumor biology, disease progression, and potential therapeutic targets. Key strategies adopted by companies in this market include developing advanced sequencing technologies, establishing collaborations with research institutions and pharmaceutical companies for data sharing and clinical trials, and enhancing bioinformatics capabilities to interpret complex genomic data effectively. The market is driven by increasing research investments in oncology, personalized medicine approaches, and the growing demand for targeted cancer therapies based on genomic profiling. Various market participants in the transcriptomics sector continue to focus on innovating new instruments and techniques for disease diagnostics.

Recent Developments:

In August 2021, HTG Molecular Diagnostics, Inc. launched its HTG Transcriptome Panel in the U.S. and Europe. This panel, utilizing HTG EdgeSeq technology, can measure nearly 20,000 mRNA targets and has demonstrated repeatability for diagnosing multiple cancers. These advancements and launches are expected to bolster growth within this segment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUMOR TRANSCRIPTOMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

10x Genomics

Agilent Technologies Inc.

BGI Genomics

Bio-Rad Laboratories Inc.

Dovetail Genomics

F. Hoffmann-La Roche AG

Fluidigm Corporation

GE Healthcare

Illumina Inc.

Merck KGaA

Natera Inc.

Others

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

• Consumables
• Instruments
• Other Products

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Diagnostics and Disease Profiling
• Drug Discovery
• Other Applications

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• Microarray
• Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
• Sequencing Technologies

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Tumor Transcriptomics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Tumor Transcriptomics Market Snippet by Product type
  • 2.1.2. Tumor Transcriptomics Market Snippet by Application
  • 2.1.3. Tumor Transcriptomics Market Snippet by Technology
  • 2.1.4. Tumor Transcriptomics Market Snippet by Country
  • 2.1.5. Tumor Transcriptomics Market Snippet by Region
• 2.2. Competitive Insights

3. Tumor Transcriptomics Key Market Trends

• 3.1. Tumor Transcriptomics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Tumor Transcriptomics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Tumor Transcriptomics Market Opportunities
• 3.4. Tumor Transcriptomics Market Future Trends

4. Tumor Transcriptomics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Tumor Transcriptomics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Tumor Transcriptomics Market Landscape

• 6.1. Tumor Transcriptomics Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Tumor Transcriptomics Market - By Product type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product type, 2023 & 2032 (%)
  • 7.1.2. Consumables
  • 7.1.3. Instruments
  • 7.1.4. Other Products

8. Tumor Transcriptomics Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Diagnostics and Disease Profiling
  • 8.1.3. Drug Discovery
  • 8.1.4. Other Applications

9. Tumor Transcriptomics Market - By Technology

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
  • 9.1.2. Microarray
  • 9.1.3. Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
  • 9.1.4. Sequencing Technologies

10. Tumor Transcriptomics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Tumor Transcriptomics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Tumor Transcriptomics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Tumor Transcriptomics Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Tumor Transcriptomics Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Tumor Transcriptomics Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Tumor Transcriptomics Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. 10x Genomics
  • 11.2.2. Agilent Technologies Inc.
  • 11.2.3. BGI Genomics
  • 11.2.4. Bio-Rad Laboratories Inc.
  • 11.2.5. Dovetail Genomics
  • 11.2.6. F. Hoffmann-La Roche AG
  • 11.2.7. Fluidigm Corporation
  • 11.2.8. GE Healthcare
  • 11.2.9. Illumina Inc.
  • 11.2.10. Merck KGaA
  • 11.2.11. Natera Inc.
  • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us